Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2022-10-06 Declaration of Voting R…
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 septembre 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated October 6, 2022, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 30 septembre 2022" (Information relative to the total number of voting rights and shares comprising the capital as of September 30, 2022). It explicitly states the total number of shares and voting rights, referencing French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the total number of shares and voting rights is typically classified as a notification of changes in significant share ownership or capital structure, often falling under Major Shareholding Notification (MRQ) or a general regulatory filing (RNS). Since it details the total capital structure as of a specific date, it is most closely aligned with tracking ownership/capital changes. Given the options, MRQ (Major Shareholding Notification) is the closest fit for reporting total share count, although it is a general capital disclosure. However, since it is a formal regulatory disclosure about the capital structure (shares and voting rights), and not a dividend announcement (DIV) or a general share issue (SHA), it fits best under the category tracking significant ownership/capital changes or the general regulatory fallback. Because it is a specific, periodic disclosure about the total number of shares and voting rights, it is a common requirement often grouped with major shareholding updates or general regulatory filings. Given the specific nature of reporting total voting rights, it is a regulatory filing. If a more specific category existed for 'Total Voting Rights Disclosure', that would be ideal. In the absence of that, and noting it's a formal regulatory disclosure, RNS (Regulatory Filings) is the safest general classification, but MRQ relates directly to share count changes. Let's re-evaluate the definitions. MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document reports the total count, which is required periodically regardless of crossing a threshold. Therefore, RNS (Regulatory Filings) as a general mandatory disclosure is more appropriate than MRQ, which implies crossing a specific threshold. The document length is short (2690 chars), but it contains the full required data, not just an announcement of a report, so RPA is incorrect. RNS is the best fit for a mandatory, non-specific regulatory disclosure.
2022-10-06 French
Europlasma met fin à son contrat de financement obligataire
Capital/Financing Update Classification · 99% confidence The document is a press release dated October 5, 2022, announcing that Europlasma is terminating its convertible bond financing contract (OCABSA) with GCFO 11. This action directly relates to the company's financing structure and capital management strategy. Among the provided definitions, 'Capital/Financing Update' (CAP) is the most appropriate category for announcements regarding the termination or initiation of financing agreements, debt restructuring, or capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific, material financing event.
2022-10-05 French
EUROPLASMA: TIRAGE DE 1 TRANCHE DE 100 OBLIGATIONS CONVERTIBLES EN ACTIONS
Capital/Financing Update Classification · 99% confidence The document is titled "Communiqué de presse" (Press Release) and announces a specific financial action: the drawing down of a tranche of convertible bonds (OCA) for 1 million euros, detailing the terms of the financing program with Global Corporate Finance Opportunities 11. This announcement relates directly to the company's capital structure and fundraising activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific financing event.
2022-09-28 French
EUROPLASMA: Point de situation concernant les résultats consolidés estimés du 1er semestre 2022
Earnings Release Classification · 99% confidence The document is a press release dated September 23, 2022, providing estimated consolidated results for the first half (1er semestre) of 2022. It explicitly mentions that the full semi-annual report ('rapport semestriel') containing the consolidated financial statements will be made available later (by October 31, 2022). Since this document only announces preliminary results and points to a future, more comprehensive report, it fits the definition of an initial announcement of periodical financial results, which corresponds to the Earnings Release (ER) category. Although it contains some financial figures, its primary function here is the preliminary announcement, not the comprehensive report itself (which would be an IR). Given the context of preliminary H1 results, ER is the most appropriate fit over IR (Interim Report) which usually implies the full, filed document. H1 2022
2022-09-23 French
EUROPLASMA: TIRAGE DE 1 TRANCHE DE 100 OBLIGATIONS CONVERTIBLES EN ACTIONS
Capital/Financing Update Classification · 99% confidence The document is titled "Communiqué de presse" (Press Release) and announces the drawing of a tranche of convertible bonds (OCA) for 1 million euros, detailing the financing agreement with GCFO 11. It discusses the use of funds, operational acceleration, and potential shareholder dilution. This type of announcement, detailing a specific financing event, capital structure change, or debt issuance, aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital action.
2022-09-21 French
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 août 2022
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated September 6, 2022, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 août 2022" (Information relative to the total number of voting rights and shares comprising the capital as of August 31, 2022). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of periodic disclosure regarding the total share capital and voting rights is a standard regulatory filing, but it specifically relates to the structure of ownership and voting power, which aligns closely with notifications about significant shareholding changes or capital structure updates. However, given the options, this specific disclosure about the total number of shares and voting rights, often required monthly or quarterly, is best categorized as a general regulatory announcement that doesn't fit the specific definitions of 10-K, ER, or IR. Since it is a formal disclosure of capital structure metrics required by regulators, and it is not a dividend notice (DIV), share issue (SHA), or transaction in own shares (POS), the most appropriate general regulatory category is RNS, or potentially MRQ if it were strictly about crossing thresholds, but RNS serves as the best general regulatory filing bucket for mandatory disclosures not covered elsewhere. Given the content is a formal declaration of the total number of shares and voting rights, it is a mandatory regulatory disclosure.
2022-09-06 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.